PLGA-based nanoparticles as regenerative medicine

Deepika Sharma, Smruti Rekha Rout, Gowtham Kenguva, Mahender Khatravath, Gaurav K. Jain, Geeta Aggarwal, Prashant Kesharwani, Rambabu Dandela

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Scopus citations

Abstract

Nanoparticles (NPs) are spherically-shaped solids with an average 100nm size, synthesized from naturally or synthetically occurring polymers. Nowadays, nanotechnology is being widely used in biomedical science for treating a number of diseases like cancer. Poly(lactic-co-glycolic acid) (PLGA) is a successful biodegradable polymer due to its hydrolytic property, and has been approved by the FDA and EMA. PLGA NPs are incorporated in cells via fluid phase pinocytosis as well as via clathrin-mediated endocytosis. Over the past 2 decades, regenerative medicine has been studied widely due to its ability to repair or replace cells and tissues that have been impacted by age, illness, or injuries, and also to normalize congenital abnormalities. This chapter discusses the use of PLGA-based nanoparticles in regenerative medicine.

Original languageEnglish
Title of host publicationPoly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery
PublisherElsevier
Pages335-356
Number of pages22
ISBN (Electronic)9780323912150
ISBN (Print)9780323914314
DOIs
StatePublished - 1 Jan 2023
Externally publishedYes

Keywords

  • CeO
  • Chrysin
  • Drug delivery
  • Nanomedicine
  • Nanoparticles
  • PLGA
  • PLGA-PEG
  • Polymer
  • Regenerative medicines

ASJC Scopus subject areas

  • General Engineering
  • General Materials Science

Fingerprint

Dive into the research topics of 'PLGA-based nanoparticles as regenerative medicine'. Together they form a unique fingerprint.

Cite this